• Japanese
  • Korean
  • Chinese
Cover Image

Autoinjectors to 2020: Devices, Markets, Players, Strategies and Forecasts

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, participants and commercial opportunities within the autoinjector segment of the prefilled syringe market. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Device Evolution and the Evolving Landscape for Injectable Drugs

Syringes that can be prefilled on standard fill-and-finish lines have had a dramatic effect on the way injectable drugs are developed, prescribed and administered. This impact has been accelerated by the introduction and evolution of autoinjectors - devices that are designed to accept a standard prefilled syringe and form an outer user-friendly device package that simplifies the injection process. While autoinjectors are sometimes designed to work with a particular injectable product as a form of pharmaceutical branding, the typical autoinjector is designed to fit one or more standard sizes of prefilled disposable syringes. Autoinjectors enable a significantly larger segment of the patient population to self-administer injectables. This report analyzes eleven important therapeutic segments and examines the impact of autoinjectors on injectable drug markets.

Highlights

  • Analyzes therapeutic demand drivers and evaluates commercial autoinjector products in eleven major therapeutic segments
  • Analyzes design factors, material selection issues, technologies and market development issues
  • Profiles autoinjector device market participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Provides market data and forecasts to 2020

Table of Contents

  • Executive Summary
  • The Market Opportunity
  • Delivery Market Dynamics
  • The Economics of Injectable Drugs
  • What's Driving the Growth in Autoinjectors?
  • Prefilled Syringes Proliferating
  • The Trend toward Self-Administration
  • Shifting Demographics
  • Innovation in Disposable Device Designs
  • Therapeutic Demand Drivers
  • Competitive Landscape
  • Risk Factors
  • Autoinjectors - Commercial Devices
  • Manual Injection Autoinjectors
  • Automated Injection Autoinjectors
  • Reusable Autoinjectors
  • Disposable Autoinjectors
  • Variable Dose Autoinjectors
  • Product Specific Autoinjectors
  • Autoinjector Device Design Factors
  • Material Selection Issues
  • Part Counts and Device Cost
  • Safety Features
  • Needle Shielding
  • Needle Insertion Depth
  • Failsafe Activation
  • Dose Inspection/Injection Confirmation
  • Lyophilized Drugs/Reconstitution
  • Human Engineering/Ergonomics
  • Autoinjector Drug Delivery - Key Therapeutic Sector Analysis
  • Anticoagulants
  • Autoimmune Diseases
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Psoriasis
  • Emergency Medicine
  • Epipen
  • Hepatitis
  • Hematopoietics
  • Hormones
  • Reproductive Health
  • Market Factors
  • Regulatory Issues
  • Device Branding
  • Patient Compliance and Ease of Use
  • Healthcare Economics
  • Company Profiles
Show More
Pricing